IUCrJ

IUCrJ

IUCrJ May 2020, Vol 7 No. 3 Read the abstract

spinning image of plasmodium hexokinase protein showing four subunits in blue, magenta, purple and orange

UBC discovery opens new avenues for designing drugs to combat drug-resistant malaria

UBC News | Phys.org [May 1, 2020] For the first time, UBC researchers have shown a key difference in the three-dimensional structures of a key metabolic enzyme in the parasite that causes malaria compared to its human counterpart

Subramaniam Lab awarded Rapid Response Funding for COVID Research

Subramaniam Lab awarded Rapid Response Funding for COVID Research

GenomeBC [April 30, 2020] Structure-guided design of therapeutics and antibodies against COVID-19

UBC discovery opens new avenues for designing drugs to combat drug-resistant malaria

UBC discovery opens new avenues for designing drugs to combat drug-resistant malaria

EurekAlert! [April 30, 2020] The finding, recently published in the International Union of Crystallography Journal (IUCrJ), brings researchers one step closer to developing new therapies to combat drug-resistant malaria

Subramaniam Lab listed as one of key groups working on COVID-19 at UBC

Subramaniam Lab listed as one of key groups working on COVID-19 at UBC

UBC COVID-19 Research [April 17, 2020] UBC researchers across all domains are focusing on many different aspects of COVID-19 and its impacts.